missing translation for 'onlineSavingsMsg'
Learn More

Dabrafenib, TRC

Product Code. 30009339
Change view
Click to view available options
Quantity:
10 mg
25 mg
50 mg
Unit Size:
10mg
25mg
50mg
3 product options available for selection
Product selection table with 3 available options. Use arrow keys to navigate and Enter or Space to select.
Product Code. Quantity unitSize
30009339 50 mg 50mg
30005522 10 mg 10mg
30007488 25 mg 25mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 3 options available.
3 options
This item is not returnable. View return policy
Product Code. 30009339 Supplier Toronto Research Chemicals Supplier No. TRCD10100050MG

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

High-purity organic molecules and analytical standards, strategically delivered worldwide to empower innovation and commercial success.

TRUSTED_SUSTAINABILITY

Chemical Identifiers

CAS 1195765-45-7
Formula Weight 519.101
InChI Formula InChI=1S/C23H20F3N5O2S2/c1-23(2,3)21-30-18(19(34-21)16-10-11-28-22(27)29-16)12-6-4-9-15(17(12)26)31-35(32,33)20-13(24)7-5-8-14(20)25/h4-11,31H,1-3H3,(H2,27,28,29)
IUPAC Name N-[3-[5-(2-aminopyrimidin-4-yl)-2-tert-butyl-1,3-thiazol-4-yl]-2-fluorophenyl]-2,6-difluorobenzenesulfonamide
Molecular Formula C23H20F3N5O2S2
Molecular Weight (g/mol) 519.56
SMILES CC(C)(C)C1=NC(=C(S1)C2=NC(=NC=C2)N)C3=C(C(=CC=C3)NS(=O)(=O)C4=C(C=CC=C4F)F)F
Synonym N-[3-[5-(2-Amino-4-pyrimidinyl)-2-(1,1-dimethylethyl)-4-thiazolyl]-2-fluorophenyl]-2,6-difluoro-benzenesulfonamide, Dabarefenib, GSK 2118436, Tafinlar, GSK 2118436A
Chemical Name or Material Dabrafenib

Specifications

Quantity 50 mg
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.